Unfortunately, there’s every indication that today’s event at Brookings will feature more of the same kind of misguided rhetoric on perceived issues with the patent system which don’t truly exist. The evidence for this starts with the moderator for the day’s final roundtable discussion, titled Realigning Incentives to Increase Patent Quality. The moderator for this discussion will be Tim Lee, senior reporter of tech policy for Ars Technica. Lee has written in the past on the effects of “ridiculous patent litigation” and has given space to viewpoints which want to limit patentability in certain sectors, such as in business methods. Lee has also been very critical of appellate court decisions in patent cases in recent years to the point that assertions he’s made on case law regarding the patentability of software inventions border on the ridiculously absurd. This individual, who has a clearly anti-patent viewpoint, will be controlling the discussion during the final panel roundtable on patent policy.
Earlier this month, Kiss frontman Gene Simmons filed to trademark the “Devil Horns” hand gesture, but this unusual application was soon after abandoned. The application listed the date of first use as November 14, 1974, and the specimen of use was a photograph of Simmons flashing the hand gesture alongside Foo Fighters’ Dave Grohl. Just two weeks later, Simmons reconsidered if he had valid trademark rights to the hand gesture, as he abandoned the application.
Google tries to strike a “patent peace” with a new cross-licensing initiative for Android developers. The Federal Circuit is petitioned for review of a judgment in a patent case on the grounds that arbitration flouted public policy. A couple of Texas academic institutions square off in a patent battle over cancer treatments. Also, a House bill moves forward which would make the Register of Copyrights a Presidential appointee.
Many of the University of Texas’s medical developments involve the use of synthetic materials to aid in treating patients. One patent application would protect a scaffold for tissue engineering that biodegrades and delivers treatment over time. Another application describes a system of using nanoparticles to stimulate hyperthermia to treat tumors. A third application discusses an improved bioadhesive for sealing tissues together. Other notable patent application filings pertain to improved systems of diagnosing and treating diseases that usually cause a poor prognosis in patients. One patent application deals with a system of analyzing gene expressions to determine a patient’s susceptibility to renal cell carcinoma. A final application we feature provides for a more effective course of treatment for most gastrointestinal tract infections.
Normally when we discuss the impact of the Bayh-Dole Act, allowing universities and small companies to commercialize inventions made with federal support, we focus on the life sciences where the resulting new drugs and therapies dramatically improved lives for millions around the world. However, the celebration of Earth Day is an appropriate time to consider the contributions our publicly funded research organizations– partnering with an entrepreneurial private sector– make in protecting our environment.